C07K 16/125
From chlamydiales
Official title: {from Chlamydiales (O)}
C07K16/125 (From chlamydiales) appears on 53 US grants and 52 published applications in this corpus.
Search patents in C07K- Granted patents
- 53
- Published applications
- 52
- Assignees
- 33
- Inventors
- 85
- Latest grant
- 30 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 2 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 2 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 2 | 0 |
| 1999 | 0 | 0 |
| 2000 | 2 | 0 |
| 2001 | 2 | 2 |
| 2002 | 2 | 1 |
| 2003 | 1 | 2 |
| 2004 | 0 | 4 |
| 2005 | 3 | 4 |
| 2006 | 1 | 2 |
| 2007 | 3 | 4 |
| 2008 | 2 | 2 |
| 2009 | 2 | 1 |
| 2010 | 4 | 2 |
| 2011 | 0 | 3 |
| 2012 | 3 | 2 |
| 2013 | 1 | 5 |
| 2014 | 5 | 3 |
| 2015 | 2 | 3 |
| 2016 | 4 | 1 |
| 2017 | 2 | 2 |
| 2018 | 1 | 2 |
| 2019 | 1 | 1 |
| 2020 | 1 | 0 |
| 2021 | 1 | 1 |
| 2022 | 0 | 0 |
| 2023 | 1 | 3 |
| 2024 | 0 | 1 |
| 2025 | 0 | 0 |
| 2026 | 1 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Antigen binding polypeptides, antigen binding polypeptide complexes and methods of use thereof30 Jun 2026US 12,668,645 B2ModeX Therapeutics, Inc.
- Methods of treating viral infections by administering an antibody preparation comprising IGG, IGA and IGM10 Oct 2023US 11,780,909 B2Biotest AG
- IgG, IgA and IgM antibody preparations, method of making and method of use in treatment23 Mar 2021US 10,954,290 B2Biotest AG
- Chlamydia antigens21 Jul 2020US 10,716,842 B2Glaxosmithkline Biologicals SA
- Chlamydia vaccine24 Sep 2019US 10,420,829 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Antigen binding polypeptides, antigen binding polypeptide complexes and methods of use thereof17 Sep 2026US 2026/0274995 A1ModeX Therapeutics, Inc.
- Method and kit for detecting presence and/or amount of bacteria in food/drink sample, environmental sample, or biological sample29 Feb 2024US 2024/0069021 A1Asahi Kasei Kabushiki Kaisha
- Antigen binding polypeptides, antigen binding polypeptide complexes and methods of use thereof27 Jul 2023US 2023/0235092 A1ModeX Therapeutics, Inc.
- Antigen binding polypeptides, antigen binding polypeptide complexes and methods of use thereof20 Jul 2023US 2023/0227553 A1ModeX Therapeutics, Inc.
- Antigen binding polypeptides, antigen binding polypeptide complexes and methods of use thereof29 Jun 2023US 2023/0203199 A1ModeX Therapeutics, Inc.
Most cited
By later US patents
- Isolation of principal outer membrane protein and antigen of Chlamydia trachomatis34US 4,427,782 A1984
- Antigen for trachoma lymphogranuloma venereum (LGV) and non-gonococcal urethritis (NGU)23US 4,118,469 AResearch Corporation · 1978
- Nucleotide, deduced amino acid sequence, isolation and purification of heat-shock chlamydial proteins23US 5,071,962 AThe United State of America as represented by the Department of Health and Human Services · 1991
- Treatment and diagnosis of alzheimer's disease20US 7,189,703 B2Intracell, LLC · 2007
- Method for diagnosing a patient for chlamydia15US 5,716,793 AAnimal House, Inc. · 1998